SWOT Analysis Strength: The myocardial infarction market has witnessed considerable research and development in the past decade. Three major companies have developed novel drugs to treat myocardial infarction. Several clinical trials have proven the efficacy and safety of these new drug entities. Weakness: The treatment landscape remains dominated by generics due to patent expiries of...
The Myocardial Infarction Market is estimated to be valued at US$ 1,816.8 Mn in 2023 and is expected to exhibit a CAGR of 5.9 % over the forecast period from 2021 to 2028, as highlighted in a new report published by Coherent Market Insights. Market Overview:Myocardial infarction, commonly known as a heart attack, occurs due to reduced blood flow and oxygen delivery to the heart muscle. It...
Market Dynamics:
One of the major drivers for the growth of the myocardial infarction market is the increasing incidences of cardiovascular diseases globally. According to the World Health Organization (WHO), cardiovascular diseases are the number one cause of death across the world. Every year 17.9 million people die from CVDs, which represent 31% of all global deaths. High blood...
A thorough discussion in the world class Cardiac Marker Testing report is sure to help client in studying the market on competitive landscape and has analysis of prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, and applications globally while considering the past, present and future state of the...